SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001102624-16-003395
Filing Date
2016-09-20
Accepted
2016-09-20 16:15:39
Documents
1
Period of Report
2016-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 BOSTON THERAPEUTICS, INC. 8-K boston8k.htm 8-K 24029
  Complete submission text file 0001102624-16-003395.txt   25594
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54586 | Film No.: 161894053
SIC: 2834 Pharmaceutical Preparations